Literature DB >> 14765879

Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute.

M Nilsson1, J S Wang, L Wielanek, K E Tanner, L Lidgren.   

Abstract

An injectable material consisting of calcium sulphate mixed with hydroxyapatite was investigated as a possible alternative to autograft in the restoration of bone defects. The material was studied both in vitro in simulated body fluid (SBF) and in vivo when implanted in rat muscles and into the proximal tibiae of rabbits. Variation in the strength and weight of the material during ageing in SBF was measured. Tissue response, material resorption and bone ingrowth were studied in the animal models. A good tissue response was observed in both the rat muscles and rabbit tibiae without inflammatory reactions or the presence of fibrous tissue. Ageing in SBF showed that during the first week carbonated hydroxyapatite precipitated on the surfaces of the material and this may enhance bone ingrowth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14765879

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  33 in total

1.  Osteoporotic vertebral compression fractures augmentation by injectable partly resorbable ceramic bone substitute (Cerament™|SPINE SUPPORT): a prospective nonrandomized study.

Authors:  Salvatore Masala; Giovanni Nano; Stefano Marcia; Mario Muto; Francesco Paolo Maria Fucci; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2011-08-11       Impact factor: 2.804

2.  Bone healing using a bi-phasic ceramic bone substitute demonstrated in human vertebroplasty and with histology in a rabbit cancellous bone defect model.

Authors:  H P Hatten; M J Voor
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

3.  Osteoporotic vertebral compression fracture augmentation by injectable partly resorbable ceramic bone substitute (Cerament™|SPINESUPPORT): a prospective nonrandomized study.

Authors:  Salvatore Masala; Giovanni Nano; Stefano Marcia; Mario Muto; Francesco P M Fucci; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2012-03-06       Impact factor: 2.804

4.  Treatment of painful Modic type I changes by vertebral augmentation with bioactive resorbable bone cement.

Authors:  Salvatore Masala; Giovanni Carlo Anselmetti; Stefano Marcia; Giovanni Nano; Amedeo Taglieri; Eros Calabria; Marcello Chiocchi; Giovanni Simonetti
Journal:  Neuroradiology       Date:  2014-05-01       Impact factor: 2.804

5.  Initial clinical experience with a new biointegrative cement for vertebroplasty in osteoporotic vertebral fractures.

Authors:  S Siemund; L T Nilsson; M Cronqvist; B Strömqvist
Journal:  Interv Neuroradiol       Date:  2009-11-04       Impact factor: 1.610

6.  Ectopic osteogenesis of an injectable nHAC/CSH loaded with blood-acquired mesenchymal progenitor cells in a nude mice model.

Authors:  Xue Han; Xia Wu; Hongchen Liu; Dongsheng Wang; Lingling E; Wei Zhou
Journal:  J Mater Sci Mater Med       Date:  2015-01-11       Impact factor: 3.896

7.  Bioceramic vertebral augmentation with a calcium sulphate/hydroxyapatite composite (Cerament SpineSupport): in vertebral compression fractures due to osteoporosis.

Authors:  Michael Rauschmann; Thomas Vogl; Akhil Verheyden; Robert Pflugmacher; Thomas Werba; Sven Schmidt; Johannes Hierholzer
Journal:  Eur Spine J       Date:  2010-02-04       Impact factor: 3.134

8.  Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.

Authors:  Wei-Tao Jia; Qiang Fu; Wen-Hai Huang; Chang-Qing Zhang; Mohamed N Rahaman
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

9.  Augmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite.

Authors:  Efstathios Drampalos; Hasan Raza Mohammad; Anand Pillai
Journal:  J Orthop       Date:  2019-08-13

10.  Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study.

Authors:  Jacek Kaczmarczyk; Piotr Sowinski; Maciej Goch; Katarzyna Katulska
Journal:  BMC Musculoskelet Disord       Date:  2015-11-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.